Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Tuesday preview: UK consumer credit, Barclays in focus

(Sharecast News) - Financial markets' attention on Tuesday will be on UK consumer credit and mortgage lending data for the month of June. The day is to be released at 0830 BST.

Also of interest will be US house price survey results, for May, due out at 1300 BST.

They will be followed 1400 BST by a reading on US consumer confidence courtesy of the Conference Board.

In parallel, the Department of Labor will release its JOLTS job market survey covering the month of June.

On the corporate side of things, Barclays is due to release its interim results.

For the first quarter, the bank had posted a 19% surge in pre-tax profits to reach £2.7bn with total income ahead by 11% to £7.7bn.

At the time, the lender also guided towards a full-year return on tangible equity of approximately 11% and group net interest income, excluding the Investment Bank and Head Office, of over £12.5bn.

Tuesday 29 July

INTERIMS

AstraZeneca, Canal+ S.A (CDI), Convatec Group , Croda International, Essentra, Greggs, Inchcape, Morgan Sindall Group, Morgan Sindall Group, Restore, Shaftesbury Capital, Staffline Group, SThree, Unilever

INTERNATIONAL ECONOMIC ANNOUNCEMENTS

Consumer Confidence (US) (15:00)

House Price Index (US) (14:00)

Q2

AstraZeneca

GMS

GreenX Metals Limited NPV (DI)

FINALS

Altitude Group, IG Design Group, NWF Group

AGMS

Coro Energy, Switch Metals, Triad Group, Verici DX , Vodafone Group

TRADING ANNOUNCEMENTS

Entain

UK ECONOMIC ANNOUNCEMENTS

BRC Shop Price Index (00:01)

Consumer Credit (09:30)

M4 Money Supply (09:30)

Mortgage Approvals (09:30)

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.